Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Levothyroxine (LT4) is a form of thyroid hormone used to treat hypothyroidism. In the brain, T4 is converted to the active form T3 by type 2 deiodinase (D2). Thus, it is intriguing that carriers of the Thr92Ala polymorphism in the D2 gene (DIO2) exhibit clinical improvement when liothyronine (LT3) is added to LT4 therapy. Here, we report that D2 is a cargo protein in ER Golgi intermediary compartment (ERGIC) vesicles, recycling between ER and Golgi. The Thr92-to-Ala substitution (Ala92-D2) caused ER stress and activated the unfolded protein response (UPR). Ala92-D2 accumulated in the trans-Golgi and generated less T3, which was restored by eliminating ER stress with the chemical chaperone 4-phenyl butyric acid (4-PBA). An Ala92-Dio2 polymorphism-carrying mouse exhibited UPR and hypothyroidism in distinct brain areas. The mouse refrained from physical activity, slept more, and required additional time to memorize objects. Enhancing T3 signaling in the brain with LT3 improved cognition, whereas restoring proteostasis with 4-PBA eliminated the Ala92-Dio2 phenotype. In contrast, primary hypothyroidism intensified the Ala92-Dio2 phenotype, with only partial response to LT4 therapy. Disruption of cellular proteostasis and reduced Ala92-D2 activity may explain the failure of LT4 therapy in carriers of Thr92Ala-DIO2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, HEK-293 cells stably expressing Thr92Ala-DIO2 produced ∼20% less T3 over time than cells expressing Thr92-DIO2 (20).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The previously mentioned alterations in activity, sleep, and cognition were intensified when the homozygous mice were rendered hypothyroid by adding methimazole to their drinking water.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, carriers of the Thr92Ala polymorphism demonstrate a hypothyroid-like state in the brain [46].”
From T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, it may cause intracellular organelle dysfunction by abnormal translocation to the Golgi apparatus and disruption of mitochondrial function, apoptosis, and growth factor signalling (18, 38).”
From Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design (2023) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It reduces D2 “activity” in the mouse pituitary and HEK-293 cells (38, 41).”
From Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design (2023) · cites this paper as [38]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
The novel object recognition memory: neurobiology, test procedure, and its modifications
Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationEstrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358
Barlowe, C. (1994) · Cell · doi:10.1016/0092-8674(94)90138-4 · Cited by 1,327
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Self-citationER stress and the unfolded protein response in neurodegeneration
Hetz, C., & Saxena, S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.99 · Cited by 1,013
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Self-citationEmerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 807
Cited by
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationSelenium in thyroid disorders—essential knowledge for clinicians
Winther, K. H., Rayman, M. P., Bonnema, S. J., & Hegedüs, L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0311-6 · Cited by 288
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationDeiodinases and the Three Types of Thyroid Hormone Deiodination Reactions
Sabatino, L., Vassalle, C., Seppia, C. D., & Iervasi, G. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1198 · Cited by 187
Deiodinases control local cellular and systemic thyroid hormone availability
Köhrle, J., & Frädrich, C. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.024 · Cited by 133
Deiodinases and the Metabolic Code for Thyroid Hormone Action
Russo, S. C., Salas-Lucia, F., & Bianco, A. C. (2021) · Endocrinology · doi:10.1210/endocr/bqab059 · Cited by 139
Self-citationZhang, Z.-H., & Song, G.-L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.646518 · Cited by 124
Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime
Duntas, L. H., & Jonklaas, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01078-2 · Cited by 93
Huwiler, V. V., Maissen‐Abgottspon, S., Stanga, Z. G., Mühlebach, S., Trepp, R., Bally, L., & Bano, A. (2024) · Thyroid · doi:10.1089/thy.2023.0556 · Cited by 127
“Consequently, some individuals may exhibit modulated inflammatory responses, 89 endoplasmic reticulum stress in the brain, 90 susceptibility to selenium deficiency, and specific response to selenium supplementation.”
BackgroundOptimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Giammanco, M., Liegro, C. M. D., Schiera, G., & Liegro, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114140 · Cited by 99
“produced; this situation can be improved by eliminating ER stress with the chemical chaperone 4-phenyl butyric acid (4-PBA) [56].”
BackgroundJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Self-citationIndividualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
Ettleson, M. D., & Bianco, A. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa430 · Cited by 75
Self-citationThyroid hormone system disrupting chemicals
Köhrle, J., & Frädrich, C. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101562 · Cited by 78
T3 levels and thyroid hormone signaling
Salas-Lucia, F., & Bianco, A. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044691 · Cited by 66
“A common polymorphism in the DIO2 gene (Thr92AlaDIO2), which alters the intracellular localization of the enzyme and reduces D2 activity by ~20%, has been associated with impaired effectiveness of LT4 in the treatment of hypothyroidism, and clinical improvement when liothyronine (LT3) was added to LT4 therapy (73, 86–…”
BackgroundInfluentialSelf-citationAccelerating functional gene discovery in osteoarthritis
Butterfield, N. C., Curry, K. F., Steinberg, J., Dewhurst, H. F., Komla-Ebri, D. S. K., Mannan, N. S., Adoum, A., Leitch, V. D., Logan, J. G., Waung, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20761-5 · Cited by 69
Self-citationTolerance to Selenoprotein Loss Differs between Human and Mouse
Santesmasses, D., Mariotti, M., & Gladyshev, V. N. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz218 · Cited by 63
“Thr92Ala (rs225014) in DIO2, which has an impact on thyroid function in humans (Jo et al. 2019).”
BackgroundThyroid Hormone Deiodinases: Dynamic Switches in Developmental Transitions
Hernández, A., Martinez, M. E., Ng, L., & Forrest, D. (2021) · Endocrinology · doi:10.1210/endocr/bqab091 · Cited by 62
PNECAT Group, Tost, M., Monreal, J. A., Armario, A., Barbero, J. D., Cobo, J., García‐Rizo, C., Bioque, M., Usall, J., Huerta‐Ramos, E., et al. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00854-w · Cited by 57
Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Samuels, M. H., & Bernstein, L. J. (2022) · Thyroid · doi:10.1089/thy.2022.0139 · Cited by 64
“T3-responsive genes in brain areas show decreased T3 effects in these mice, and the behavioral deficits are improved more with LT4/LT3 than LT4 monotherapy (16,57).”
Thyroid hormone, gene expression, and Central Nervous System: Where we are
Giannocco, G., Kizys, M. M. L., Maciel, R. M. B., & de Souza, J. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.007 · Cited by 59
The relevance of T3 in the management of hypothyroidism
Salvatore, D., Porcelli, T., Ettleson, M. D., & Bianco, A. C. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00004-3 · Cited by 41
Self-citationEmerging roles of ER-resident selenoproteins in brain physiology and physiopathology
Jehan, C., Cartier, D., Bucharles, C., Anouar, Y., & Lihrmann, I. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102412 · Cited by 42
“Thr92Ala is a well-studied polymorphism present in 12–36% of the population that leads to ER stress and hypothyroidism [166].”
BackgroundEmerging Therapies in Hypothyroidism
Bianco, A. C. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101007 · Cited by 44
Self-citationT4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
Menikdiwela, K. R., Guimarães, J. P. T., Ramalingam, L., Kalupahana, N. S., Dufour, J. M., Washburn, R. L., & Moustaïd‐Moussa, N. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1925219 · Cited by 37
“Moreover, the emerging role of ER stress in the brain (specifically causation of brain inflammation and Alzheimer’s disease) and chronic gastric infection (causing mucosal injury in obese individuals) has been studied over recent years (Jo et al. 2019; Salminen et al. 2020; Wen et al. 2021).”
BackgroundAxonal T3 uptake and transport can trigger thyroid hormone signaling in the brain
Salas-Lucia, F., Fekete, C., Sinkó, R., Egri, P., Rada, K., Ruska, Y., Gereben, B., & Bianco, A. C. (2023) · eLife · doi:10.7554/elife.82683 · Cited by 33
Self-citationPasternak, J. A., MacPhee, D. J., & Harding, J. C. S. (2020) · Veterinary Research · doi:10.1186/s13567-020-00772-2 · Cited by 31
van Vliet, N. A., Kamphuis, A. E. P., den Elzen, W. P. J., Blauw, G. J., Gussekloo, J., Noordam, R., & van Heemst, D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab674 · Cited by 30
Mapping Thyroid Hormone Action in the Human Brain
Salas-Lucia, F. (2024) · Thyroid · doi:10.1089/thy.2024.0120 · Cited by 35
“124 TSH levels in the high normal range are also associated with cortical atrophy and a higher proportion of infarct-like vascular lesions in male subjects aged 65 – 83.”
Cardiovascular and Neuronal Consequences of Thyroid Hormones Alterations in the Ischemic Stroke
Murolo, M., Vincenzo, O. D., Cicatiello, A. G., Scalfi, L., & Dentice, M. (2022) · Metabolites · doi:10.3390/metabo13010022 · Cited by 34
“Moreover, mice with the reduced D2 activity due to the Ala92-Dio2 polymorphism displayed reduced physical activity, slept more and required additional time to memorize objects, while T3 replacement improved the cognition [53].”
BackgroundThe Physiological Functions and Polymorphisms of Type II Deiodinase
Deng, Y., Han, Y., Gao, S., Dong, W., & Yu, Y. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1599 · Cited by 37
Critical Approach to Hypothyroid Patients With Persistent Symptoms
Biondi, B., Celi, F. S., & McAninch, E. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad224 · Cited by 34
Self-citationLarsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt‐Rasmussen, U., Knudsen, N. J., Bjørner, J. B., Schomburg, L., Demircan, K., Chillon, T. S., et al. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0175 · Cited by 42
The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy
McAninch, E. A., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00446 · Cited by 24
“In a novel animal model of Thr92AlaD2 expression, there was evidence of ER stress and neurocognitive dysfunction; with administration of LT3 to animals with intact endogenous thyroids, the phenotype improved, bolstering support for the positive findings in many clinical trials (34).”
ResultSelf-citationT4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Wiersinga, W. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.501 · Cited by 21
Brain hypothyroidism silences the immune response of microglia in Alzheimer’s disease animal model
Kim, D. K., Choi, H., Lee, W., Choi, H., Hong, S. B., Jeong, J., Han, J., Han, J. W., Ryu, H., Kim, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi1863 · Cited by 27
“Inactivation of DIO2 by a common polymorphism (Thr 92 Ala), which is susceptible to ubiquitination and degradation, has been linked to tissue-specific hypothyroidism ( 50 , 51 ).”
BackgroundEndoplasmic reticulum stress at the forefront of fatty liver diseases and cancer
Karin, M., & Kim, J. Y. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100096 · Cited by 28
Casula, S., Ettleson, M. D., & Bianco, A. C. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.003 · Cited by 21
Self-citationSustained Pituitary T3 Production Explains the T4-mediated TSH Feedback Mechanism
Batistuzzo, A., Salas-Lucia, F., Gereben, B., Ribeiro, M. O., & Bianco, A. C. (2023) · Endocrinology · doi:10.1210/endocr/bqad155 · Cited by 18
Self-citationZhao, D., Zeng, L., Liang, G.-H., Luo, M.-H., Pan, J.-K., Dou, Y., Lin, F.-Z., Huang, H., Yang, W., & Liu, J. (2024) · Bone and Joint Research · doi:10.1302/2046-3758.132.bjr-2023-0074.r1 · Cited by 18
“74 providing further evidence that reducing thyroid hormone signalling can prevent OA.”
BackgroundShi, Z., Han, Z., Chen, J., & Zhou, J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167246 · Cited by 22
Zhao, W., Bohleber, S., Schmidt, H., Seeher, S., Howard, M. T., Braun, D., Arndt, S., Reuter, U., Wende, H., Birchmeier, C., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009369 · Cited by 21
“Whereas kinetic studies had previously shown only moderate changes in catalytic activity, the mouse model clearly showed a brain-specific ER stress provoked by the missense mutation (35).”
BackgroundGene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism
Penna, G., Salas-Lucia, F., Ribeiro, M. O., & Bianco, A. C. (2023) · Endocrine · doi:10.1007/s12020-023-03528-y · Cited by 20
“Disruption of cellular proteostasis and reduced Ala92-D2 activity may help explain the failure of LT4 therapy in patients with hypothyroidism that carry the Thr92Ala-DIO2 allele [85].”
InfluentialSelf-citationIdentification of Resistance to Exogenous Thyroxine in Humans
Lacámara, N., Beatriz Lecumberri, S., Barquiel, B., Escribano, A., Casado, I. G., Álvarez‐Escolá, C., Blanquer, F. A., Morales, F., Alfayate, R., Bernal-Soriano, M. C., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0825 · Cited by 17
“Ala92-D2 rodents show signs of brain hypothyroidism (19).”
InfluentialManaging symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15
Kang, Y. E., Kang, Y. M., Park, B., Shong, M., & Yi, H. (2019) · Clinical Endocrinology · doi:10.1111/cen.14206 · Cited by 15
Li, P., Teng, Y., Ru, X., Liu, Z., Han, Y., Tao, F., & Huang, K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab887 · Cited by 15
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back
Rurale, G., Cicco, E. D., Dentice, M., Salvatore, D., Persani, L., Marelli, F., & Luongo, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00912 · Cited by 14
“This mouse model showed hypothyroidism in distinct brain areas associated with memory, and behavior issues that improved after T3 administration were aggravated by primary hypothyroidism and responded only partially to LT4 treatment (38).”
Backgroundde Lima Beltrão, F. E., de Almeida Beltrão, D. C., Carvalhal, G., de Lima Beltrão, F. E., de Souza Braga Filho, J., de Brito Oliveira, J., de Jesus, J. D. S., Machado, G. J. R., dos Santos Silva, H., Teixeira, H. M. P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac075 · Cited by 12
“It causes the substitution of threonine for an alanine at position 92, which has reduced activity (28, 29).”
BackgroundSelf-citationWang, X., Chen, K., Zhang, C., Wang, H., Li, J., Wang, C., Teng, W., Shan, Z., & Lai, Y. (2021) · BioMed Research International · doi:10.1155/2021/9914009 · Cited by 13
“Acting as a cargo protein in ER and Golgi complex vesicles, Ala92-Dio2 causes ER stress and induces the unfolded protein response (UPR), and the specific symptoms can be improved by agents eliminating ER stress or the administration of LT3 [24].”
BackgroundJonklaas, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934003 · Cited by 13
“Biomarkers of euthyroidism that could reveal this tissue hypothyroidism have been investigated in animal studies (19, 20), but have not been studied in a rigorous manner in humans and deserve further”
BackgroundThr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective
Ricci, C., Kakularam, K. R., Marzocchi, C., Capecchi, G., Riolo, G., Boschin, F., Kühn, H., Castagna, M. G., & Cantara, S. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01287-5 · Cited by 13
Luongo, C., De Stefano, M. A., Ambrosio, R., Volpe, F., Porcelli, T., Golia, V., Bellevicine, C., Troncone, G., Masone, S., Damiano, V., et al. (2023) · Thyroid · doi:10.1089/thy.2022.0472 · Cited by 11
“31 This study indicates that, even if Thr92Ala D2 enzymatic activity is estimated to be reduced by only 20–30%, this reduction is sufficient to induce significant changes in TH homeostasis under specific circumstances.”
Cognitive function in hypothyroidism: what is that deiodinase again?
Hernández, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci125203 · Cited by 10
Novel methods for the generation of genetically engineered animal models
Cassidy, A., Onal, M., & Pelletier, S. W. (2022) · Bone · doi:10.1016/j.bone.2022.116612 · Cited by 8
Chronic asthenia in patients who have undergone endocrine neck surgery
Scerrino, G., Melfa, G., Brutto, D. L., Mazzola, S., Corigliano, A., Vitale, I., Tutino, R., Rotolo, G., Orlando, G., & Cocorullo, G. (2021) · Endocrine · doi:10.1007/s12020-021-02838-3 · Cited by 9
“On the other hand, it has been demonstrated that T2 is a strong stimulator of oxygen consumption in mitochondria [15, 42–44], and, more recently, a reduced intracellular T3 production has been demonstrated in the presence of deiodinase mutation [45].”
BackgroundSun, Y. J., Teng, D., Zhao, L., Shi, X., Li, Y., Shan, Z., & Teng, W. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0084 · Cited by 9
de Almeida, G. G., Bolin, A. P., Batistuzzo, A., Fonseca, T. L., Ribeiro, M. O., & Bianco, A. C. (2024) · Endocrinology · doi:10.1210/endocr/bqae064 · Cited by 6
Self-citationUter, J. C., Krämer, U. M., Schöls, L. J., Rodríguez‐Fornells, A., Göbel, A., Heldmann, M., Lichtner, P., Brabant, G. E., & Münte, T. F. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1065-1786 · Cited by 9
Uter, J. C., Krämer, U. M., Schöls, L. J., Rodríguez‐Fornells, A., Göbel, A., Heldmann, M., Lichtner, P., Brabant, G. E., & Münte, T. F. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1102-8862 · Cited by 7
Premawardhana, L. D., Taylor, P. N., Okosieme, O. E., Adlan, M. A., Obuobie, E. K., & Dayan, C. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282608 · Cited by 6
“However, it may cause intracellular organelle dysfunction by abnormal translocation to the Golgi apparatus and disruption of mitochondrial function, apoptosis, and growth factor signalling (18, 38).”
BackgroundInfluentialDsouki, N. A., Pereira, B. F., da Silva, R. G., Rodrigues, V. G., Brito, R. D. S., Kizys, M. M. L., Chiamolera, M. I., Maciel, R. M., Serrano-Nascimento, C., & Giannocco, G. (2024) · Endocrines · doi:10.3390/endocrines5040036 · Cited by 6
Age Worsens the Cognitive Phenotype in Mice Carrying the Thr92Ala-DIO2 Polymorphism
Lorena, F. B., Sato, J., COVIELLO, B. M., Arnold, A. J. T., Batistuzzo, A., Yamanouchi, L. M., Dias, E. P., do Nascimento, B. P. P., Fonseca, T. D. L., Bianco, A. C., et al. (2022) · Metabolites · doi:10.3390/metabo12070629 · Cited by 7
“Given that in previous studies the phenotype observed in the young male Ala-Dio2 mouse was rescued by treatment with LT3 [6], we also tested whether this would happen with older male Ala92-Dio2 mice.”
BackgroundResultSelf-citationCan Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?
Szklarz, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191911990 · Cited by 10
“Lipid droplets in iron deficient adrenal cells were much less developed compared with cells with a normal iron supply [235].”
BackgroundAssessment of children in the autistic spectrum disorder that carry the Thr92Ala-DIO2 polymorphism
Marcondes, A. A. E., Gomez, T. G. B., Ravache, T. T., Batistuzzo, A., Lorena, F. B., Paula, C. S., Lowenthal, R., Bianco, A. C., & Ribeiro, M. O. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01497-x · Cited by 7
Self-citationKang, Y. M., Koo, B. S., Yi, H., Kim, J. T., Park, B., Lee, J. H., Shong, M., & Kang, Y. E. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.292 · Cited by 7
“A total of 7,213 cohort members aged 40 to 69 years were assessed biennially with scheduled on-site follow-up visits at baseline (2001 to 2002) [24-27].”
MethodShared Decisionmaking in the Treatment of Hypothyroidism
Bianco, A. C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15228 · Cited by 7
“It has been reported that a common single ‐ nucleotide polymorphism (SNP) in the gene encoding D2 (DIO2) reduces its catalytic activity by about 40% [29, 30].”
Self-citationFunkquist, A., Bengtsson, A. A., Johansson, P., Svensson, J., Bjellerup, P., Blennow, K., Wandt, B., & Sjöberg, S. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100218 · Cited by 9
“However, these results are conflicting with a recent study in mice, which reported that a DIO2 polymorphism affected brain function [32].”
ResultMetabolic Consequences of Thyroidectomy and Patient-Centered Management
Wang, K., & Güleç, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237465 · Cited by 7
Schweizer, U., & Fabiano, M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104083 · Cited by 10
“A humanized mouse model expressing the Ala92 variant showed decreased DIO2 activity and T3 levels in the brain, and showed ER-stress, although these transgenic mice expressed a His-and YFP-tagged engineered protein [174].”
Schwengber, W. K., Silveira, V. B., Hetzel, G. M., Robaina, A., Ceolin, L., Camelier, M. T. V., Goemann, I. M., Corte, R. R. D., Scheffel, R. S., de Mello, R. G. B., et al. (2022) · Metabolites · doi:10.3390/metabo12050375 · Cited by 7
“The Type 2 deiodinase (DIO2) enzyme is essential to maintain adequate levels of T3 in the intracellular environment of specialized tissues, such as the central nervous system (CNS) [1].”
BackgroundLevothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
Hennessey, J. V. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.013 · Cited by 4
Ahmed, Z., Sherin, R. P. V., Fonseca, T. L., Hoang, T. D., & Shakir, M. K. M. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5651 · Cited by 2
Self-citationA DIO2 missense mutation and its impact on fetal response to PRRSV infection
Ko, H., Pasternak, J. A., Mulligan, M. K., Hamonic, G., Ramesh, N., MacPhee, D. J., Plastow, G. S., & Harding, J. C. S. (2024) · BMC Veterinary Research · doi:10.1186/s12917-024-04099-4 · Cited by 5
“…DIO2 (Thr92Ala), i.e. the first residue of the destruction loop, has been demonstrated to alter enzymatic characteristics of DIO2, including longer half-life (~ 2.5 fold increase) [30], greater stability [31], less efficient T4 to T3 conversion [31] or decreased in vivo T4 5’ deiodination [32].”
BackgroundInfluentialThyroid Hormone and Alcoholic Fatty Liver: The Developmental Input
Hernández, A. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14145 · Cited by 3
“This polymorphism has a relatively high prevalence in humans and leads in vivo to endoplasmic reticulum stress and impaired DIO2 function (Jo et al., 2018).”
BackgroundTargeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Porcelli, T., & Salvatore, D. (2020) · Endocrine · doi:10.1007/s12020-020-02391-5 · Cited by 3
Thyroid Hormone Pathways in Respiratory Diseases: Mechanism and Therapeutic Potential
Małujło-Balcerska, E., Gałecka, M., & Pietras, T. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s529790 · Cited by 3
Thyroid hormones and metabolic flexibility: tissue-specific control of energy homeostasis
Cicatiello, A. G., Miro, C., Sagliocchi, S., Nappi, A., & Dentice, M. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1882438 · Cited by 3
“Mechanistically, Thr92Ala appears to impair D2 catalytic ef fi ciency and/or intracellular processing, thereby reducing T3 generation in D2-expressing tissues such as SkM, adipose tissue, and brain (Castagna et al., 2017; Jo et al., 2019).”
Beltrão, D. C. D. A., Beltrão, F. E. D. L., Carvalhal, G., Beltrão, F. L. D. L., Brito, A. D. S., Silva, H. D. S., Teixeira, H. M. P., Rodrigues, J. L., Figueiredo, C. A., Costa, R. D. S., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1366500 · Cited by 2
“This protection may be explained by the association of Thr92Ala-DIO2 gene expression with endoplasmic reticulum (ER) stress, in fl ammation, oxidative stress, apoptosis, and mitochondrial dysfunction (33).”
BackgroundBatistuzzo, A., Zhang, X., Bocco, B. M. L. C., McAninch, E. A., Salas-Lucia, F., Ribeiro, M. O., Arvan, P., Bianco, A. C., & Fonseca, T. L. (2025) · Endocrinology · doi:10.1210/endocr/bqaf046 · Cited by 1
Self-citationThe Year in Basic Thyroidology
Cheng, S.-Y. (2019) · Thyroid · doi:10.1089/thy.2019.0768 · Cited by 2
“Thus, to gain insight into these mechanisms, Jo and colleagues first studied cell lines stably expressing Thr92-D2 or Ala92-D2 tagged with fluorescence probes and found that Ala92-D2 causes endoplasmic reticulum (ER) stress and accumulates in the Golgi apparatus (11).”
BackgroundIs euthyroidism within reach for all?
Jonklaas, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267120 · Cited by 2
“The ‘holy grail’ of euthyroidism, however, is likely to be the perfect balance of thyroid hormones at a cellular level [9,10], which has been most thoroughly investigated in animal models [11,12].”
BackgroundAdvances in hypothyroidism management: rethinking therapy beyond levothyroxine
Ditshego, R., Pick, J., & Ncube, K. N. (2025) · SA pharmaceutical journal. · doi:10.36303/sapj.3267 · Cited by 1
Sıçanlarda 6-n-propil-2-tiourasil ile bozulan öğrenme ve bellek performansına selenyumun etki
Koşar, B., Tan, B., Altunkaya, M., Süer, C., & Dursun, N. (2022) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.1096963 · Cited by 1
Thyroid hormone, thyroid medication, and the skeleton
Freudenthal, B., Watts, L., Bassett, J. H. D., & Williams, G. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00046-0
Self-citationEssentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer
Aydoğan, B. İ., & Gürsoy, A. (2021) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2021.0002 · Cited by 1
Pasión e identidad: el problema del conocimiento en el "De anima" de Aristóteles
Martín, J. I. A. S. (1999) · Dialnet (Universidad de la Rioja)
Rol de la suplementación de selenio en el tratamiento del hipotiroidismo
Clavijo, A. ́. G., Loaiza, J. D. M., Márquez-Fernández, A., RODRIGUEZ, L. M., González, L. A. C., Cedeño, D. F. A., & Serna, L. F. R. (2021) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.8.2.603
“[21] Jo S, Fonseca TL, Bocco BMLC, Fernandes GW, McAninch EA, Bolin AP, et al.”
BackgroundVariation in Thyroid Hormone Metabolism May Affect COVID-19 Outcome
Persani, L., & Campi, I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac152
“In previous studies, the authors documented the association of the heterozygous Ala/Thr-D2 genotype with inflammatory markers, such as CXCR4 and SLC44A that are today known to also play a relevant role in the most severe manifestations of COVID-19 disease (1, 6).”
BackgroundMamoor, S. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/x7mn6
Therapeutic use of triiodothyronine in hypothyroidism: Current status and the road ahead
Das, S. (2023) · Journal of Integrative Medicine and Research · doi:10.4103/jimr.jimr_7_23
Recommendations for managing patients with hypothyroidism
Hardy, C. (2024) · JAAPA · doi:10.1097/01.jaa.0000000000000005 · Cited by 2
Beltrão, F. E. D. L., Beltrão, D. C. D. A., Carvalhal, G., Beltrão, F. L. D. L., Oliveira, J. D. B., Silva, H. D. S., Teixeira, H. M. P., Rodrigues, J. L., Figueiredo, C. A., Costa, R. D. S., et al. (2024) · European Thyroid Journal · doi:10.1530/etj-24-0068
Self-citationBernal, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274226124010007
Papel do inflamassoma NLRP3 em modelos associados ao remodelamento cardíaco.
Parletta, A. C. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2024.tde-08102024-090803
Precision Thyroid Hormone Therapy for Hypothyroidism
Bianco, A. C., & Beltrão, F. E. D. L. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_24
Self-citationER stress in D1-MSNs mediates cocaine-induced behavioral plasticity via the ATF4–SPTLC1 axis
Zhao, Y., Li, S., Jiang, L., Zhao, Y., Kuang, W., Wei, Q., Zhou, Y., Han, S., Wang, L., Li, H., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1677343 · Cited by 1
Additional file 3 of A DIO2 missense mutation and its impact on fetal response to PRRSV infection
Ko, H., Pasternak, J. A., Mulligan, M. K., Hamonic, G., Ramesh, N., MacPhee, D. J., Plastow, G. S., & Harding, J. C. S. (2024) · Figshare · doi:10.6084/m9.figshare.26732812
Metadata
- Authors
- Jo, S., Fonseca, T. L., Bocco, B. M. L. C., Fernandes, G. W., McAninch, E. A., Bolin, A. P., Da Conceição, R. R., Werneck-de-Castro, J. P., Ignacio, D. L., Egri, P., Németh, D., Fekete, C., Bernardi, M. M., Leitch, V. D., Mannan, N. S., Curry, K. F., Butterfield, N. C., Bassett, J. H. D., Williams, G. R., Gereben, B., Ribeiro, M. O., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of Chicago (US)
- HUN-REN Institute of Experimental Medicine (HU)
- Universidade Paulista (BR)
- Imperial College London (GB)
- Universidade Presbiteriana Mackenzie (BR)
- Corresponding author
- Bianco, Antonio C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-12-03
- Volume
- 129
- Issue
- 1
- Pages
- 230-245
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6307951
- OpenAlex
- W2896534485
- Cited by
- 107
- References
- 78
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 13 · 2022: 17 · 2021: 16 · 2020: 15 · 2019: 12 · 2018: 1
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- NIDDK (DK58538, DK65055)
- EU H2020 “Thyrage” (666869)
- The Wellcome Trust Joint Investigator Award (110141/Z/15/Z.)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- type 2 deiodinase, endoplasmic reticulum stress, unfolded protein response, levothyroxine therapy, liothyronine, 4-phenylbutyric acid, proteostasis, cognitive impairment, thyroid hormone signaling
- MeSH terms
- Iodothyronine Deiodinase Type II, Animals, Brain, Endoplasmic Reticulum, Golgi Apparatus, Humans, Hypothyroidism, Iodide Peroxidase, Mice, Transgenic, Polymorphism, Genetic, Thyroxine, Triiodothyronine, Amino Acid Substitution, Mutation, Missense, Mice, Unfolded Protein Response, HEK293 Cells, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.